Harbour BioMed and Evinova China have formed a collaboration to implement AI and digital technologies to improve biologics development. The partnership intends to enhance the efficiency of AI-enabled ...

Manchester researchers have developed a systematic methodology to test whether AI can think logically in biomedical research, helping to ensure safer, more reliable applications in health care ...

PerturbAI, an AI-native biotechnology company, today announced results from its year-long collaboration with OpenAI to advance biomedical research and drug discovery. Working with Scripps Research, ...

Dr. Ruo-Kai Lin, Professor at TMU and Chief of R&D at EG BioMed, noted: “Through questionnaires and personalized analysis, we hope to help users understand their risks and inform discussions with ...

CAMBRIDGE, Mass., ROTTERDAM, Netherlands and SHANGHAI, Nov. 7, 2025 /PRNewswire/ -- Harbour BioMed ("HBM" or the "Company"; HKEX: 02142), a global biopharmaceutical company committed to the discovery ...

Newswise — (Toronto, May 6, 2025) JMIR Publications invites submissions to a new theme issue titled “AI Applications in Biomedical Engineering” in its open access journal JMIR Biomedical Engineering.

Generative artificial intelligence (AI) powered by human language has made remarkable progress and gained widespread use through tools such as ChatGPT. While it is mostly known for helping with ...

Newswise — ROCKVILLE, MD (January 24, 2025) — The Federation of American Societies for Experimental Biology (FASEB) has released comprehensive recommendations for responsibly integrating generative ...

Researchers at Rochester Institute of Technology developed new artificial intelligence techniques to extract and visualize information from standard-of-care biomedical data, providing a means for ...

JMIR Publications invites submissions to a new theme issue titled “AI Applications in Biomedical Engineering” in its open access journal JMIR Biomedical Engineering. AI is rapidly advancing biomedical ...